Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-10 Purchase |
2020-08-11 4:03 pm |
Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer |
4,000 | $25.97 | $103,880 | 7,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-22 Option Award |
2021-09-24 4:44 pm |
N/A 2031-09-21 |
Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-09-02 Exercise |
2021-09-07 08:03 am |
N/A 2029-07-25 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
7,500 | $0 | 219,472 (Direct) |
View |
| 2021-09-02 Exercise |
2021-09-07 08:03 am |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
7,500 | $11.51 | 219,472 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-01 6:00 pm |
N/A 2027-11-10 |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
10,000 | $0 | 546,672 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-01 6:00 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
10,000 | $1.02 | 546,672 (Direct) |
View |
| 2021-08-26 Option Award |
2021-08-30 4:52 pm |
N/A 2031-08-26 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-03 8:18 pm |
N/A 2021-07-30 |
Oyster Point Pharma Inc. | OYST | Santel Donald J Director |
25,284 | $0 | 25,284 (Direct) |
View |
| 2021-07-28 Exercise |
2021-07-29 5:05 pm |
N/A 2029-07-25 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
7,500 | $0 | 219,472 (Direct) |
View |
| 2021-07-28 Exercise |
2021-07-29 5:05 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
7,500 | $11.51 | 219,472 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:58 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director |
8,665 | $0 | 4,626,589 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:54 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | Eliades George Christopher Director |
8,665 | $0 | 30,250 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:52 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | Behbahani Ali Director |
8,665 | $0 | 15,265 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:51 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | WEISNER AIMEE S Director |
8,665 | $0 | 38,390 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:48 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | Tsai Benjamin Director |
8,665 | $0 | 15,265 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:45 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | Murray Mark Anthony Director |
8,665 | $0 | 123,712 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:44 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director |
8,665 | $0 | 1,435,104 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:43 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | ATIEH MICHAEL G Director |
8,665 | $0 | 28,360 (Direct) |
View |
| 2021-05-12 Other |
2021-05-14 4:45 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner |
404,844 | $0 | 3,736,306 (Indirect) |
View |
| 2021-05-12 Other |
2021-05-14 4:44 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner |
405,037 | $0 | 3,743,857 (Indirect) |
View |
| 2021-05-12 Other |
2021-05-14 4:42 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director |
10,944 | $0 | 1,416,779 (Indirect) |
View |
| 2021-04-02 Option Award |
2021-04-05 7:32 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Eliades George Christopher Director |
21,585 | $0 | 21,585 (Direct) |
View |
| 2021-04-02 Exercise |
2021-04-02 2:11 pm |
N/A 2027-11-10 |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
10,000 | $0 | 546,672 (Direct) |
View |
| 2021-04-02 Exercise |
2021-04-02 2:11 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
10,000 | $1.02 | 546,672 (Direct) |
View |
| 2021-03-26 Other |
2021-03-30 9:45 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director |
10,933 | $0 | 1,738,484 (Indirect) |
View |
| 2021-03-26 Other |
2021-03-30 7:05 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner |
404,849 | $0 | 3,738,334 (Indirect) |
View |
| 2021-03-26 Other |
2021-03-30 6:58 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner |
405,042 | $0 | 3,745,692 (Indirect) |
View |
| 2021-02-24 Exercise |
2021-02-26 7:50 pm |
N/A 2029-07-25 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
9,109 | $0 | 219,472 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-26 7:50 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
9,109 | $11.51 | 219,472 (Direct) |
View |
| 2021-02-19 Exercise |
2021-02-23 8:13 pm |
N/A 2027-11-10 |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
10,000 | $0 | 546,672 (Direct) |
View |
| 2021-02-19 Exercise |
2021-02-23 8:13 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
10,000 | $1.02 | 546,672 (Direct) |
View |
| 2021-02-17 Other |
2021-02-19 5:16 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner |
337,107 | $0 | 5,604,496 (Direct) |
View |
| 2021-02-17 Other |
2021-02-19 5:13 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner |
337,479 | $0 | 3,374,952 (Indirect) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:35 pm |
N/A 2031-01-28 |
Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer |
61,722 | $0 | 68,722 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:33 pm |
N/A 2031-01-28 |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
142,437 | $0 | 148,437 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:32 pm |
N/A 2031-01-28 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
61,722 | $0 | 76,022 (Direct) |
View |
| 2020-12-10 Other |
2020-12-14 8:45 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director |
983,334 | $0 | 3,032,612 (Indirect) |
View |
| 2020-10-08 Option Award |
2020-10-13 07:29 am |
N/A N/A |
Oyster Point Pharma Inc. | OYST | ATIEH MICHAEL G Director |
19,695 | $0 | 19,695 (Direct) |
View |
| 2020-09-25 Exercise |
2020-09-28 6:12 pm |
N/A 2029-07-25 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
4,000 | $0 | 208,250 (Direct) |
View |
| 2020-09-25 Exercise |
2020-09-28 6:12 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
4,000 | $11.51 | 208,250 (Direct) |
View |
| 2020-08-11 Exercise(A) |
2020-08-18 6:18 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
4,000 | $11.51 | 10,300 (Direct) |
View |
| 2020-08-11 Exercise |
2020-08-12 8:32 pm |
N/A 2029-07-25 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
4,000 | $0 | 201,950 (Direct) |
View |
| 2020-08-11 Exercise |
2020-08-12 8:32 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
4,000 | $11.51 | 201,950 (Direct) |
View |
| 2020-07-28 Exercise |
2020-07-30 7:37 pm |
N/A 2027-11-10 |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
5,000 | $0 | 520,774 (Direct) |
View |
| 2020-07-28 Exercise |
2020-07-30 7:37 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
5,000 | $1.02 | 520,774 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 9:18 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director |
6,600 | $0 | 3,572,146 (Direct) |
View |